Avanir Pharms Drug Patent Portfolio

Avanir Pharms owns 1 orange book drug protected by 3 US patents Given below is the list of Avanir Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7659282 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders 13 Aug, 2026
Active
US8227484 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders 17 Jul, 2023 Expired
USRE38115 Dextromethorphan and an oxidase inhibitor for treating intractable conditions 26 Jan, 2016 Expired


Given below is the list of recent legal activities going on the following drug patents of Avanir Pharms.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed 11 Mar, 2024 US8227484
Payment of Maintenance Fee, 12th Year, Large Entity 28 Jul, 2021 US7659282 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 09 Jan, 2020 US8227484
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 16 Oct, 2014 US8227484
Recordation of Patent Grant Mailed 24 Jul, 2012 US8227484
Patent Issue Date Used in PTA Calculation 24 Jul, 2012 US8227484
Email Notification 05 Jul, 2012 US8227484
Issue Notification Mailed 04 Jul, 2012 US8227484
Email Notification 29 Jun, 2012 US8227484
PG-Pub Issue Notification 28 Jun, 2012 US8227484
Dispatch to FDC 23 Jun, 2012 US8227484
Application Is Considered Ready for Issue 13 Jun, 2012 US8227484
Electronic Review 11 Jun, 2012 US8227484
Mail Applicant Initiated Interview Summary 11 Jun, 2012 US8227484
Email Notification 11 Jun, 2012 US8227484


Avanir Pharms's Family Patents

Avanir Pharms drugs have patent protection in a total of 22 countries. It's US patent count contributes only to 20.3% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Avanir Pharms Drug List

Given below is the complete list of Avanir Pharms's drugs and the patents protecting them.


1. Nuedexta

Nuedexta is protected by 3 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7659282 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders 13 Aug, 2026
(1 year, 8 months from now)
Active
US8227484 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders 17 Jul, 2023
(1 year, 3 months ago)
Expired
USRE38115 Dextromethorphan and an oxidase inhibitor for treating intractable conditions 26 Jan, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nuedexta's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List